Rising Demand For Personalized Medicine Fuelling The Growth Of The Next-Generation In Vitro Diagnostics (IVD) Market Due To Increasing Availability Of Genomic Data Continues To Impact The Growth Of The Next-Generation In Vitro Diagnostics (IVD) Market
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Next-Generation In Vitro Diagnostics (IVD) Market Projected To Expand During 2026–2030?
The next-generation in vitro diagnostics (ivd) market has experienced rapid expansion in recent years. This market is projected to grow from $117.97 billion in 2025 to $129.89 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. The growth observed in the historical period stems from the increasing prevalence of infectious diseases, the rising burden of chronic conditions, a greater uptake of molecular diagnostics, the enlargement of clinical laboratory infrastructure, and government financial support for diagnostic programs.
The next-generation in vitro diagnostics (ivd) market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach $188.69 billion, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected growth is driven by factors such as the rising demand for precision medicine, the broadening applications of genomic testing, increased uptake of point-of-care diagnostics, advancing healthcare digitization, and greater investments in diagnostic research and development. Key trends expected during this forecast period encompass a move towards personalized and companion diagnostics, widespread acceptance of point-of-care and decentralized testing, the incorporation of multiplex and high-throughput assays, an escalating need for early disease detection and screening, and the expansion of non-invasive and liquid biopsy diagnostics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25848&type=smp
Which Strategic Drivers Are Supporting The Next-Generation In Vitro Diagnostics (IVD) Market Development?
The next-generation in vitro diagnostics (IVD) market’s future growth is expected to be propelled by the increasing demand for personalized medicine. Precision medicine is a healthcare methodology that customizes disease prevention and treatment based on an individual’s genetic profile, environment, and lifestyle. The rise of personalized medicine is due to the expanding availability of genomic data, which enables healthcare providers to develop targeted treatments specific to a person’s unique genetic makeup, resulting in more effective care. Next-generation in vitro diagnostics (IVD) aids personalized medicine by offering precise molecular and genetic insights crucial for tailoring treatment and prevention strategies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, stated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Hence, the rising demand for personalized medicine is a key factor driving the expansion of the next-generation in vitro diagnostics (IVD) market.
What Are The Major Segment Categories Within The Next-Generation In Vitro Diagnostics (IVD) Market?
The next-generation in vitro diagnostics (ivd) market covered in this report is segmented –
1) By Product Type: Consumables, Instruments, Software
2) By Diagnostic Modality: Core Laboratory Diagnostics, Point-Of-Care Testing, Molecular Diagnostics
3) By Application: Oncology Or Cancer, Infectious Diseases, Diabetes, Cardiology , Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users
Subsegments:
1) By Consumables: Assay Kits And Reagents, Specimen Bags and Tubes, Seals and Caps
2) By Instruments: Automated Sample Preparation Systems, High-Throughput Molecular Diagnostic Analyzers, Next-Generation Sequencing Platforms, Integrated Diagnostic Workstations And Analysis Platforms, Digital PCR Systems And Advanced Real-Time PCR Instruments
3) By Software: Laboratory Information Management Systems, Specimen Tracking Software Modules, Cloud-Based Tracking Software
What Trends Are Affecting The Next-Generation In Vitro Diagnostics (IVD) Market Dynamics?
Leading companies in the next-generation in vitro diagnostics (IVD) market are increasingly utilizing strategic partnerships. Within next-generation IVD, this approach entails collaborating with technology providers, research institutions, and healthcare organizations to accelerate innovation, enhance diagnostic precision, and expand access to advanced testing solutions for individuals, businesses, and governments. Essentially, strategic partnerships allow companies to leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in October 2024, Yourgene Health, a UK-based biotechnology firm, partnered with Genetix, a human genetic diagnosis company from Colombia, to launch Colombia’s inaugural local non-invasive prenatal testing (NIPT) service. This initiative represents a significant step forward in regional prenatal care, providing expectant parents with faster, more dependable, and cost-effective access to sophisticated genetic screening. The service employs Yourgene Health’s IONA Nx NIPT Workflow, a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow is notably flexible and scalable, suitable for varying sample volumes, thereby enabling Genetix to offer a quality-assured prenatal screening service within Colombia.
Which Companies Are Engaged In The Next-Generation In Vitro Diagnostics (IVD) Market Environment?
Major companies operating in the next-generation in vitro diagnostics (ivd) market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, Sysmex Corporation, Bio Rad Laboratories Inc, Revvity Inc, Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc, Guardant Health Inc, Pacific Biosciences Of California Inc, Transasia Bio Medicals Ltd, J Mitra And Co Pvt Ltd, Roche Diagnostics International AG, Hologic Inc, Genetron Health Inc, Seegene Inc, BGI Genomics Co Ltd, Oxford Nanopore Technologies plc
Access The Complete Next-Generation In Vitro Diagnostics (IVD) Market Report:
Which Region Commands The Largest Share Of The Next-Generation In Vitro Diagnostics (IVD) Market?
North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation in vitro diagnostics (ivd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Next-Generation In Vitro Diagnostics (IVD) Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Next-Generation In Vitro Diagnostics (IVD) Market 2026, By The Business Research Company
In Vitro Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
In Vitro Diagnostic Ivd In Cardiology And Neurology Market Report 2026
Bioinformatics In In Vitro Diagnostics Ivd Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
